These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7103956)

  • 1. Limitations on the metyrapone assay for the major phenobarbital inducible form of cytochrome P-450.
    Ivanetich KM; Costa AK; Brittain T
    Biochem Biophys Res Commun; 1982 Apr; 105(4):1322-6. PubMed ID: 7103956
    [No Abstract]   [Full Text] [Related]  

  • 2. Complexes of cytochrome P450 with metyrapone. A convenient method for the quantitative analysis of phenobarbital-inducible cytochrome P450 in rat liver microsomes.
    Mitani F; Shephard EA; Phillips IR; Rabin BR
    FEBS Lett; 1982 Nov; 148(2):302-6. PubMed ID: 7152025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metyrapone interaction with hepatic microsomal cytochrome P-450 from rats treated with phenobarbital.
    Hildebrandt AG; Leibman KC; Estabrook RW
    Biochem Biophys Res Commun; 1969 Oct; 37(3):477-85. PubMed ID: 5349284
    [No Abstract]   [Full Text] [Related]  

  • 4. Active centers of microsomal cytochrome P-450 determined with metyrapone by mutural depletion system kinetics.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):39-52. PubMed ID: 4267597
    [No Abstract]   [Full Text] [Related]  

  • 5. Metyrapone - reduced cytochrome P-450 complex: a specific method for the determination of the phenobarbital inducible form of rat hepatic microsomal cytochrome P-450.
    Luu-The V; Cumps J; Dumont P
    Biochem Biophys Res Commun; 1980 Apr; 93(3):776-81. PubMed ID: 7387674
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-competitive and competitive inhibition of mixed function oxidase in rat liver microsomes by metyrapone.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):27-38. PubMed ID: 4350469
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytochrome P-450 ligands: metyrapone revisited.
    Liu Z; Franklin MR
    Arch Biochem Biophys; 1985 Sep; 241(2):397-402. PubMed ID: 4037796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of phenobarbital-induced cytochrome P-450 in rat hepatic microsomes using an enzyme-linked immunosorbent assay.
    Seidel SL; Shawver LK; Shires TK
    Arch Biochem Biophys; 1984 Mar; 229(2):519-31. PubMed ID: 6703710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pyridine and some pyridine derivatives on spectral properties of reduced microsomes and on microsomal drug metabolizing activity.
    Jonen HG; Hüthwohl B; Kahl R; Kahl GF
    Biochem Pharmacol; 1974 Apr; 23(8):1319-29. PubMed ID: 4824776
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbon tetrachloride-altered binding of carbon monoxide to reduced cytochrome P-450 in phenobarbital microsomes.
    Bidlack WR; Advani SV; Andresen JW
    Biochem Med; 1980 Apr; 23(2):205-8. PubMed ID: 7396889
    [No Abstract]   [Full Text] [Related]  

  • 11. The monooxygenation of N-heptane by rat liver microsomes.
    Frommer U; Ullrich V; Staudinger H; Orrenius S
    Biochim Biophys Acta; 1972 Dec; 280(4):487-94. PubMed ID: 4405405
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of phenobarbital and 3-methylcholanthrene administration in vivo and isooctane extraction in vitro on metyrapone binding to reduced cytochrome P-450.
    Kahl R; Jonen HG; Kahl GF
    Biochem Pharmacol; 1974 Aug; 23(16):2305-14. PubMed ID: 4851681
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of the Ah locus with specific changes in metyrapone and ethylisocyanide binding to mouse liver microsomes.
    Kahl GF; Kahl R; Kumaki K; Nebert DW
    J Biol Chem; 1976 Sep; 251(17):5397-407. PubMed ID: 8465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the drug metabolising ability of rat intestinal mucosal microsomes with that of liver.
    Shirkey RS; Chakraborty J; Bridges JW
    Biochem Pharmacol; 1979 Sep; 28(18):2835-9. PubMed ID: 497032
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of aromatic nitro compounds with reduced hepatic microsomal cytochrome P-450.
    Sternson LA; Gammans RE
    Drug Metab Dispos; 1975; 3(4):266-74. PubMed ID: 240656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of carbon tetrachloride toxicity and cirrhosis on substrate binding to rat hepatic microsomal cytochrome P-450.
    Murray M; Farrell GC
    Biochem Pharmacol; 1984 Feb; 33(4):687-9. PubMed ID: 6704188
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of cytochrome P-450 in the N-oxidation of individual amines.
    Uehleke H
    Drug Metab Dispos; 1973; 1(1):299-313. PubMed ID: 4149397
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation and binding of carbanions by cytochrome P-450 of liver microsomes.
    Ullrich V; Schnabel KH
    Drug Metab Dispos; 1973; 1(1):176-83. PubMed ID: 4149380
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing the inhibitory effect of carbon monoxide on cytochrome P-450-catalyzed mixed function oxidation reactions.
    Estabrook RW; Franklin MR; Hildebrandt AG
    Ann N Y Acad Sci; 1970 Oct; 174(1):218-32. PubMed ID: 4332408
    [No Abstract]   [Full Text] [Related]  

  • 20. The heme protein P-450 in oxygen activation: carbon monoxide inhibition and photochemical action spectroscopy as tools to study its catalytic role.
    Schleyer H; Hamill S; Cooper DY; Rosenthal O
    Adv Exp Med Biol; 1981; 136 Pt A():119-43. PubMed ID: 7344454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.